Xuhua Qin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xuhua Qin has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Shenrui Jin
School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
9 shared publications Junyu Liu
School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
7 shared publicationsYi Xu
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China
6 shared publicationsZulun Li
School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
6 shared publicationsShenrui Jin
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
4 shared publicationsYufeng Li
School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
4 shared publications
Latest Publications
- 5 January 2026
- Published by Springer Nature in European Food Research and Technology
- Vol. 252 (2) , 46
A review on the botany, traditional edible uses, nutritional composition, phytochemical constituents, and bioactivities of Paederia foetida L.
- 5 January 2026
- Published by Springer Nature in European Food Research and Technology
- Vol. 252 (2) , 46
A review on the botany, traditional edible uses, nutritional composition, phytochemical constituents, and bioactivities of Paederia foetida L.
- 11 November 2025
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 78 (2)
Traditional uses, phytochemistry, and pharmacological effects of Sedum sarmentosum : a review
Objective: This review comprehensively summarizes the botany, traditional applications, phytochemistry, pharmacological activities, toxicology, and quality control of Sedum sarmentosum, aiming to provide a reference for its further research and development. Methods: Research articles and materials were retrieved from databases including Web of Science, PubMed, Google Scholar, CNKI, and related academic publications. Key findings: To date, 174 chemical constituents have been isolated and identified from S. sarmentosum, including volatile oils, flavonoids, terpenoids, phenolics, glycosides, and others. Modern pharmacological studies have revealed diverse bioactivities such as hepatoprotective, nephroprotective, antitumour, and antioxidant effects. Ten proprietary Chinese medicines primarily composed of S. sarmentosum have been developed for the treatment of liver diseases. Conclusions: This review provides a comprehensive overview of the traditional Chinese clinical applications, phytochemical identification, and pharmacological mechanisms of S. sarmentosum, offering insights and references for subsequent Traditional Chinese Medicine research and development, as well as in-depth studies on natural active products and pharmacological mechanisms. Current research suggests that its terpenoid components directly associated with its significant hepatoprotective effects. Moreover, the specific mechanisms underlying its hepatoprotective actions still require further investigation.
- 11 November 2025
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 78 (2)
Traditional uses, phytochemistry, and pharmacological effects of Sedum sarmentosum : a review
Objective: This review comprehensively summarizes the botany, traditional applications, phytochemistry, pharmacological activities, toxicology, and quality control of Sedum sarmentosum, aiming to provide a reference for its further research and development. Methods: Research articles and materials were retrieved from databases including Web of Science, PubMed, Google Scholar, CNKI, and related academic publications. Key findings: To date, 174 chemical constituents have been isolated and identified from S. sarmentosum, including volatile oils, flavonoids, terpenoids, phenolics, glycosides, and others. Modern pharmacological studies have revealed diverse bioactivities such as hepatoprotective, nephroprotective, antitumour, and antioxidant effects. Ten proprietary Chinese medicines primarily composed of S. sarmentosum have been developed for the treatment of liver diseases. Conclusions: This review provides a comprehensive overview of the traditional Chinese clinical applications, phytochemical identification, and pharmacological mechanisms of S. sarmentosum, offering insights and references for subsequent Traditional Chinese Medicine research and development, as well as in-depth studies on natural active products and pharmacological mechanisms. Current research suggests that its terpenoid components directly associated with its significant hepatoprotective effects. Moreover, the specific mechanisms underlying its hepatoprotective actions still require further investigation.
- 18 October 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 356, 120761
Ardisia japonica (Thunb.) Blume: Traditional applications, phytochemistry, pharmacological activities, network pharmacology, and quality control
- 18 October 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 356, 120761
Ardisia japonica (Thunb.) Blume: Traditional applications, phytochemistry, pharmacological activities, network pharmacology, and quality control
- Open Access
- 11 August 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 118828
Network toxicological mechanism analysis of pyrethroid insecticides-induced chronic respiratory system damage in humans
- 11 August 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 118828
Open AccessNetwork toxicological mechanism analysis of pyrethroid insecticides-induced chronic respiratory system damage in humans
- Open Access
- 31 May 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (6) , 1355
The Potential of Matrine in the Treatment of Breast Cancer: A Review
Breast cancer ranks as the fifth-most-prevalent malignancy worldwide, characterized by high heterogeneity and multifactorial etiology across molecular subtypes. Despite advancements in conventional therapies, including surgery and chemotherapy, persistent challenges such as treatment-related adverse effects and acquired drug resistance necessitate alternative therapeutic strategies. Matrine, a naturally occurring alkaloid derived from Sophora flavescens, has demonstrated significant anticancer potential through multiple mechanisms. Experimental evidence indicates that matrine exerts inhibitory effects on tumor cell proliferation, promotes apoptosis, and attenuates metastatic progression via modulation of critical signaling pathways, particularly PI3K/Akt, JAK/STAT, NF-κB, MAPK/ERK, and Wnt/β-catenin. This review systematically examines subtype-specific responses to matrine treatment, highlighting its potential utility in precision oncology for distinct breast cancer classifications. Furthermore, we evaluate matrine’s capacity to synergize with standard chemotherapeutic regimens, potentially overcoming drug resistance while reducing required dosages. By integrating current preclinical and clinical findings, this analysis provides new perspectives on matrine’s therapeutic applications and underscores the imperative for translational studies to establish optimized treatment protocols for clinical implementation.
- 31 May 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (6) , 1355
Open AccessThe Potential of Matrine in the Treatment of Breast Cancer: A Review
Breast cancer ranks as the fifth-most-prevalent malignancy worldwide, characterized by high heterogeneity and multifactorial etiology across molecular subtypes. Despite advancements in conventional therapies, including surgery and chemotherapy, persistent challenges such as treatment-related adverse effects and acquired drug resistance necessitate alternative therapeutic strategies. Matrine, a naturally occurring alkaloid derived from Sophora flavescens, has demonstrated significant anticancer potential through multiple mechanisms. Experimental evidence indicates that matrine exerts inhibitory effects on tumor cell proliferation, promotes apoptosis, and attenuates metastatic progression via modulation of critical signaling pathways, particularly PI3K/Akt, JAK/STAT, NF-κB, MAPK/ERK, and Wnt/β-catenin. This review systematically examines subtype-specific responses to matrine treatment, highlighting its potential utility in precision oncology for distinct breast cancer classifications. Furthermore, we evaluate matrine’s capacity to synergize with standard chemotherapeutic regimens, potentially overcoming drug resistance while reducing required dosages. By integrating current preclinical and clinical findings, this analysis provides new perspectives on matrine’s therapeutic applications and underscores the imperative for translational studies to establish optimized treatment protocols for clinical implementation.
- 15 May 2024
- Published by Elsevier in Phytomedicine
- Vol. 130, 155749
Plant-derived inducers in tumor differentiation therapy:A systematic review
- 15 May 2024
- Published by Elsevier in Phytomedicine
- Vol. 130, 155749
Plant-derived inducers in tumor differentiation therapy:A systematic review
- 8 April 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 329, 118107
Paeonia lactiflora Pall. ameliorates acetaminophen-induced oxidative stress and apoptosis via inhibiting the PKC-ERK pathway
- 8 April 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 329, 118107
Paeonia lactiflora Pall. ameliorates acetaminophen-induced oxidative stress and apoptosis via inhibiting the PKC-ERK pathway
- Open Access
- 7 September 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 974054
Chinese endemic medicinal plant Bolbostemma paniculatum (Maxim.) Franquet: A comprehensive review
Bolbostemma paniculatum (Maxim.) Franquet is a unique species in China with a long history of medicinal use, which has the effects of detoxifying, dissolving lumps and dispersing swellings. And it is commonly used to treat many diseases, such as carbuncle and sore, acute mastitis, mammary cancer, scrofula and subcutaneous nodule traditionally. Modern clinical studies have found that B. paniculatum and its compounds can be used for the treatment of a variety of cancers, mastitis, hyperplasia of mammary glands, chronic lymphadenitis, cervical lymph tuberculosis and surgical wart skin diseases, and the curative effect is positive. At present, a variety of Chinese patent medicines containing B. paniculatum have been exploited and marketed in China for the treatment of cancers, breast diseases and flat warts. This review article comprehensively discussed the traditional application, botany, chemical components, pharmacological activities, and quality control of B. paniculatum, put forward some noteworthy issues and suggestions in current studies, and briefly discussed the possible development potential of this plant as well as future research perspectives. 96 compounds have been isolated from B. paniculatum, including triterpenoids, sterols, alkaloids and other components, of which triterpenoid saponins are the main bioactive components. The crude extracts and monomer compounds of B. paniculatum have a wide range of pharmacological activities, such as anti-tumor, antiviral, anti-inflammatory, immunoregulatory, and so on. Moreover, its anti-tumor mechanism involves many aspects, including inhibiting cell proliferation, promoting cell apoptosis, blocking the cell cycle, interfering with cell invasion and metastasis, suppressing angiogenesis, and regulating autophagy. While there is a lack of systematic and in-depth research on its anti-tumor active components and mechanism of action at the moment; and a tight connection between the chemical composition and pharmacological activity of B. paniculatum has also not been established. Besides, a systematic quality determination standard for B. paniculatum should also be built, in order to carry out further research.
- 7 September 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 974054
Open AccessChinese endemic medicinal plant Bolbostemma paniculatum (Maxim.) Franquet: A comprehensive review
Bolbostemma paniculatum (Maxim.) Franquet is a unique species in China with a long history of medicinal use, which has the effects of detoxifying, dissolving lumps and dispersing swellings. And it is commonly used to treat many diseases, such as carbuncle and sore, acute mastitis, mammary cancer, scrofula and subcutaneous nodule traditionally. Modern clinical studies have found that B. paniculatum and its compounds can be used for the treatment of a variety of cancers, mastitis, hyperplasia of mammary glands, chronic lymphadenitis, cervical lymph tuberculosis and surgical wart skin diseases, and the curative effect is positive. At present, a variety of Chinese patent medicines containing B. paniculatum have been exploited and marketed in China for the treatment of cancers, breast diseases and flat warts. This review article comprehensively discussed the traditional application, botany, chemical components, pharmacological activities, and quality control of B. paniculatum, put forward some noteworthy issues and suggestions in current studies, and briefly discussed the possible development potential of this plant as well as future research perspectives. 96 compounds have been isolated from B. paniculatum, including triterpenoids, sterols, alkaloids and other components, of which triterpenoid saponins are the main bioactive components. The crude extracts and monomer compounds of B. paniculatum have a wide range of pharmacological activities, such as anti-tumor, antiviral, anti-inflammatory, immunoregulatory, and so on. Moreover, its anti-tumor mechanism involves many aspects, including inhibiting cell proliferation, promoting cell apoptosis, blocking the cell cycle, interfering with cell invasion and metastasis, suppressing angiogenesis, and regulating autophagy. While there is a lack of systematic and in-depth research on its anti-tumor active components and mechanism of action at the moment; and a tight connection between the chemical composition and pharmacological activity of B. paniculatum has also not been established. Besides, a systematic quality determination standard for B. paniculatum should also be built, in order to carry out further research.
- 4 August 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 298, 115584
Pyrolae herba: A review on its botany, traditional uses, phytochemistry, pharmacology and quality control
- 4 August 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 298, 115584
Pyrolae herba: A review on its botany, traditional uses, phytochemistry, pharmacology and quality control